Blueprint Medicines

Blueprint Medicines

Blueprint Medicines

Blueprint Medicines discovers and develops highly selective kinase inhibitors for patients with genomically defined cancers
Suggest edits
Founded
2011
Raised
$240M
Follow us
Also headquartered in Cambridge
Companies in the same industry
Alexa global traffic share